Skip to content
PeptideAgent

Clinics in South Carolina

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

What South Carolina law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and verified listings.

South Carolina at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified clinics serving South Carolina

No verified clinics serving South Carolina are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Peptide access rules in South Carolina

Yes. A South Carolina resident can obtain FDA approved peptides such as semaglutide and tirzepatide from a South Carolina-licensed prescriber, including by telemedicine under section 40-47-37 of the South Carolina Code, and can obtain a compounded peptide when it is eligible under federal 503A rules and dispensed by a pharmacy holding a South Carolina Board of Pharmacy permit. Out-of-state pharmacies that mail prescriptions into South Carolina need a nonresident permit under section 40-43-83, and the Board reviews compounding practices before issuing one. South Carolina has no state bulks list, so peptide compounding eligibility follows the FDA framework. [1] [2] [3] [4] [5] [6] [7] [8] [9]

Compounded GLP-1 access in South Carolina

Telehealth GLP-1 patients should confirm that the prescriber holds a South Carolina license and that any mail order pharmacy holds a South Carolina nonresident permit under section 40-43-83. [3] [5] [10]

Research use only sellers in South Carolina

The South Carolina Pharmacy Practice Act limits dispensing of prescription drugs to permitted pharmacies and licensed practitioners, so an online seller shipping "research use only" injectable peptides to South Carolina consumers is not operating as a pharmacy under chapter 43. The South Carolina Board of Medical Examiners has also issued a notice that a physician may not compound, administer, prescribe, or dispense research-grade or FDA-ineligible peptides, may not delegate those acts to APRNs or PAs, and cannot rely on a patient consent form. The notice states that facilities inside or outside South Carolina may not sell or dispense drugs without a Board of Pharmacy license (S.C. Code 40-43-83 and 40-43-89), that physicians, APRNs, PAs, and pharmacists must buy all prescription products and compounding ingredients from Board of Pharmacy permitted entities, and that buying from an unpermitted source can be misconduct under S.C. Code 40-47-110(B). [4] [11] [12]

How to check a clinic in South Carolina

  1. Confirm the prescribing clinician's license with the South Carolina medical or nursing board.
  2. Ask which pharmacy compounds or dispenses the peptide and check it in the South Carolina Board of Pharmacy (South Carolina Department of Labor, Licensing and Regulation) license lookup. [1] [4] [5] [6] [7] [8] [9]
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in South Carolina. [4] [11] [12]

Common questions in South Carolina

Can I get a GLP-1 prescription in South Carolina through telemedicine?

Yes, from a physician licensed in South Carolina who meets section 40-47-37. The physician must perform an appropriate evaluation, which can be remote, and must obtain your medical history in an interview they conduct at each encounter. Semaglutide and tirzepatide are not controlled substances, so the Schedule II and III telemedicine limits do not apply. [3]

Will a South Carolina telehealth doctor prescribe from an online form alone?

It is unlikely to be compliant. Section 40-47-37 requires the prescribing licensee to collect the information needed for an accurate diagnosis in a medical history interview at each encounter, which is hard to satisfy with a static questionnaire. Expect a video or phone visit or a live exchange with the prescriber. [2] [3]

All peptide legal questions for South Carolina

Sources

  1. [1]South Carolina Board of Pharmacy (Department of Labor, Licensing and Regulation)
  2. [2]South Carolina Board of Medical Examiners
  3. [3]South Carolina Code section 40-47-37, Practice of telemedicine, requirements (title 40, chapter 47)
  4. [4]South Carolina Code title 40, chapter 43, South Carolina Pharmacy Practice Act
  5. [5]South Carolina Code section 40-43-83, In-state facilities and out-of-state mail order pharmacy service permits
  6. [6]South Carolina Code section 40-43-86, Facility requirements for pharmacies, including compounding
  7. [7]South Carolina Board of Pharmacy: Non-Resident Pharmacy Permit Application, including non-sterile and sterile compounding requirements (revised February 2019)
  8. [8]South Carolina Board of Pharmacy: facility permit types and non-resident application review
  9. [9]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  10. [10]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  11. [11]21 U.S.C. 331, Prohibited acts
  12. [12]South Carolina Board of Medical Examiners: Notice Concerning the Prescribing of Research-Grade Peptides and FDA-Ineligible Peptides